What is the Impact Factor of Drug Metabolism Reviews?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Drug Metabolism Reviews is 4.70, ranking in quartile Q1 of Web of Science (SCIE).

Is Drug Metabolism Reviews indexed in Web of Science or Scopus?

Yes, Drug Metabolism Reviews is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.930 (Q1) and an H-index of 117.

Who publishes Drug Metabolism Reviews and what is the Article Processing Charge (APC)?

Drug Metabolism Reviews is published by Informa Healthcare. The estimated Article Processing Charge (APC) is approximately $3,308 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Drug Metabolism Reviews?

The official ISO-4 abbreviation of Drug Metabolism Reviews is "DRUG METAB. REV" with common acronym "ldmr". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #5,505Top JournalReview JournalHybrid

Drug Metabolism Reviews

Acronym:ldmr

•

Abbreviation (ISO):DRUG METAB. REV

•

Identifier (ISSN):0360-2532(Print)/1097-9883(Online)

•

Publisher:Informa Healthcare

Official Website Submission Portal Compare

Clarivate IF (2026)

4.7↑ +0.9

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Drug Metabolism Reviews

WoS Q1

Annual Impact Factor Metric

Current (2026):4.7

Scopus SJR & RankScopus Q1

0.93

#5,505

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

117

117 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate2.9%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

24articles/year

10.94% Gold OA•0% Original Research

Aims & Scope

Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.

Topics Covered (Recognized by AI)

Chemistry92.4%Biology88.7%Medicine78.7%Biochemistry69.7%Internal medicine66.2%Organic chemistry63%Pharmacology59.3%Physics56.5%Endocrinology51.8%Genetics50.5%Nuclear magnetic resonance50.4%Enzyme50%Metabolism42.4%Psychology41.6%Psychiatry38.8%Drug36.2%Drug metabolism28.7%Gene25.3%Bioinformatics20.1%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank78/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank207/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	78/356	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	207/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4.7

Articles / Year25

Total Citations17

2025

IF3.8

Articles / Year25

Total Citations95

2024

IF3.4

Articles / Year24

Total Citations249

2023

IF5.9

Articles / Year21

Total Citations290

2022

IF6.984

Articles / Year23

Total Citations406

Year	Impact Factor	Articles / Year	Total Citations
2026	4.7	25	17
2025	3.8	25	95
2024	3.4	24	249
2023	5.9	21	290
2022	6.984	23	406
2021	4.518	26	601
2020	3.956	29	1,394
2019	4.702	33	1,776
2018	4.45	24	1,200
2017	—	19	2,113
2016	—	44	1,946
2015	—	34	1,443

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,505Scopus Q1SCImago Profile

Scopus Coverage:1972, 1974-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

0.93

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

4.79

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,308 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations290

3-Year Documents61

Citable Documents61

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drug Metabolism Reviews (acronym: ldmr, abbr: DRUG METAB. REV, ISSN: 0360-2532) is a peer-reviewed international scholarly journal in the field of Medicine, published by Informa Healthcare in United States since 1972. The periodical holds a Journal Impact Factor (JIF) of 4.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 0.930 (Q1), an H-index of 117.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 24 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,308 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.